세계의 심혈관 기기 시장은 2024년에 75억 달러로 평가되었습니다. 심혈관 질환(CVDs)의 증례 증가, 기술 진보, 헬스케어 지출 증가를 배경으로 2025년부터 2034년에 걸쳐 13.5%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예측되고 있습니다.
인구의 고령화와 생활 습관병이 주된 원인이 되어 심장 관련 질병의 부담이 증가하고 있는 것이 선진적인 심혈관 솔루션 수요를 크게 밀어 올리고 있습니다. 앉아서 생활하는 습관, 잘못된 식습관, 높은 스트레스 수준이 전 세계적으로 CVD의 원인이 되고 있는 가운데 혁신적인 진단 및 치료 기기의 필요성이 그 어느 때보다 절실해지고 있습니다.
의료 기술의 최첨단 진보는 심혈관 치료에 혁명을 일으키고 있습니다. AI를 활용한 진단, 로봇 지원 수술, 저침습 수술의 도입은 회복 시간을 단축하면서 환자의 예후를 향상시키고 있습니다.
| 시장 범위 | |
|---|---|
| 시작 연도 | 2024년 |
| 예측 연도 | 2025-2034년 |
| 시작 금액 | 75억 달러 |
| 예측 금액 | 263억 달러 |
| CAGR | 13.5% |
이 시장은 기기 유형별로 심장 절제기기, 좌심방 부속기 폐쇄기기, 내시경적 혈관 채취기기로 분류됩니다. 불규칙한 심박 리듬으로 진단되는 환자 증가에 따라 낮은 침습 절제 기술의 채용이 증가하고 있습니다.
최종 용도별로는 심혈관 기기 시장은 병원, 외래수술센터(ASC), 심장 센터, 기타 의료시설로 구분됩니다. 고급 화상 처리 기술, 심장 전문 유닛, 집학적 팀을 갖춘 병원은 중요한 심혈관 증례의 주요 치료 거점인 계속하고 있습니다.
미국의 심혈관 기기 시장은 2023년에는 25억 달러였으며, 2034년에는 97억 달러로 성장할 것으로 예상됩니다. 전문가의 강력한 네트워크 등의 장점을 누리고 있습니다.치료 기법의 끊임없는 혁신과 지지적인 규제 정책이 시장 침투를 가속화하고 있습니다.
The Global Cardiovascular Devices Market was valued at USD 7.5 billion in 2024 and is projected to register a CAGR of 13.5% from 2025 to 2034, driven by rising cases of cardiovascular diseases (CVDs), technological advancements, and increasing healthcare expenditures. The escalating burden of heart-related ailments, largely fueled by an aging population and lifestyle-related disorders, is significantly propelling demand for advanced cardiovascular solutions. As sedentary habits, poor dietary choices, and high-stress levels continue to contribute to CVDs worldwide, the need for innovative diagnostic and treatment devices is becoming more pressing than ever. Additionally, greater awareness regarding preventive healthcare and early detection strategies is further boosting market adoption.
Cutting-edge advancements in medical technology are revolutionizing cardiovascular care. The introduction of AI-powered diagnostics, robotic-assisted surgeries, and minimally invasive procedures is enhancing patient outcomes while reducing recovery time. The industry is witnessing a surge in regulatory approvals, expanding access to state-of-the-art cardiovascular devices. Governments and private healthcare entities are heavily investing in research and development to introduce next-generation solutions that cater to evolving patient needs. Rising healthcare expenditures, particularly in developed economies, are facilitating the widespread availability of advanced cardiac devices, further propelling market growth. Moreover, the increasing number of outpatient cardiovascular interventions and home-based monitoring systems is making treatments more accessible and convenient for patients.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $7.5 Billion |
| Forecast Value | $26.3 Billion |
| CAGR | 13.5% |
The market is categorized by device type into cardiac ablation devices, left atrial appendage closure devices, and endoscopic vessel harvesting devices. Among these, cardiac ablation devices led the market with a valuation of USD 5.1 billion in 2024 and are projected to witness a CAGR of 13.7% over the forecast period. The rising prevalence of atrial fibrillation is a key driver behind the demand for these devices. With more individuals diagnosed with irregular heart rhythms, the adoption of minimally invasive ablation techniques is on the rise. Additionally, growing awareness about effective treatment options, coupled with continuous advancements in ablation technology, is fostering market expansion.
By end use, the cardiovascular devices market is segmented into hospitals, ambulatory surgical centers, cardiac centers, and other healthcare facilities. Hospitals dominated the sector, generating USD 4.4 billion in 2024 and accounting for 58.3% of the total revenue. A higher patient influx for complex cardiac interventions, including bypass surgeries, catheterizations, and device implantations, is solidifying hospitals' leadership in this space. Equipped with advanced imaging technologies, specialized cardiac units, and multidisciplinary teams, hospitals remain the primary treatment hubs for critical cardiovascular cases. Additionally, their ability to handle emergency and inpatient procedures makes them a preferred choice among both patients and healthcare providers.
The U.S. cardiovascular devices market stood at USD 2.5 billion in 2023 and is projected to grow to USD 9.7 billion by 2034. The country benefits from a well-established healthcare infrastructure, rapid adoption of cutting-edge cardiovascular technologies, and a strong network of skilled professionals, including cardiac surgeons, interventional cardiologists, and electrophysiologists. Continuous innovation in treatment methodologies and supportive regulatory policies are accelerating market penetration. Favorable reimbursement frameworks are further encouraging the adoption of advanced cardiovascular devices, positioning the U.S. as a leading market for cardiac care solutions.